The Obstetric Hematology Manual


The Obstetric Hematology Manual

Obstetric hematology is a fast-growing area of medicine covering the diagnosis and management of hematological problems of pregnancy. Comprehensive in approach, The Obstetric Hematology Manual addresses the many hematological conditions that can cause serious problems in pregnancy, delivery and the post-partum period for both mother and baby. Written by a team of international authorities, this text provides up-to-date, evidence-based guidelines on best care, as well as sound advice based on the experience and opinion of experts. Where appropriate, basic principles are discussed to clarify the rationale for management, and systems and procedures for disease prevention are highlighted. Many conditions and cases are discussed, including venous thromboembolism, pre-eclampsia, anemia, thrombocytopenia and inherited disorders. This book will appeal to both trainees and practitioners in obstetrics, obstetric medicine, obstetric anesthesia and hematology. It is also an accessible text for midwives, nurses, and laboratory staff.


 Reviews:

"Any condition that potentially could be related to hematology is addressed. Given the significance of maternal morbidity and mortality, this most certainly is a worthwhile contribution to the field....One striking aspect of the book is that it is aesthetically pleasing. It is difficult to make a book about hematology engaging but the authors have succeeded -- in both content and appearance -- in creating a book that is a pleasure to read....[W]ill certainly prove an invaluable addition to the libraries of clinicians who deal with these patients."
--Doody's Review Service

Handbook of Transfusion Medicine, ed DBL McClelland, United Kingdom Blood Services, 4th edn.
Intensive Care Society. Guidelines for the Introduction of Outreach Services. Intensive Care Society; 2002.
ACOG Practice Bulletin : Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstetrics and Gynecology 2006; 108: 1039–1047.
Ahonen J , Jokela R , Kortila K . An open non-randomized study of recombinant activated factor VIIa in major postpartum haemorrhage. Acta Anaesthesiologica Scandinavica 2007; 51: 929–936.
Akkad A , Oppenheimer C , Mushambi M , Pavord S . Intrapartum care for women on full anticoagulation. International Journal of Obstetric Anaesthesia 2003; 12: 188–192.
Alcock GS , Liley H . Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database of Systematic Reviews 2002; (3): CD003313.
Alfirevic Z , Elbourne D , Pavord S et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000–2004. Obstetrics and Gynecology 2007; 110: 1270–1278.
Allam J , Cox M , Yentis S M . Cell salvage in obstetrics. International Journal of Obstetric Anesthesia 2008; 17: 37–45.
Allen D , Verjee S , Rees S et al. Platelet transfusion in neonatal alloimmune thrombocytopenia. Blood 2007; 109: 388–389.
American Academy of Family Practitioners (AAFP) Advanced Life Support in Obstetrics. Syllabus Updates 2008. www.aafp.org/online/en/home/cme/aafpcourses/clinicalcourses/also/syllabus.html#Parsys0003 downloaded 21/05/2008
American College of Obstetricians and Gynecologists Committee on Obstetric Practice . ACOG committee opinion. Safety of Lovenox in pregnancy. Number 276, October 2002. Committee on Obstetric Practice. International Journal of Gynaecology and Obstetrics 2002 ; 79: 299–300.
Aronoff GR , Bennett WM , Blumenthal S et al. Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. Kidney International 2004; 66: 1193–1198.
Asahina T , Kobayashi T , Takeuchi K et al. Blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstetrical and Gynecological Survey 2007; 62: 255–260.
Asakai R , Chung DW , Davie EW , Seligsohn U . Factor XI deficiency in Ashkenazi Jews in Israel. New England Journal of Medicine 1991; 325: 153–158.
Asghar F , Bowman P . A Clinical Approach to the Management of Thrombosis in Obstetrics Part 2 : diagnosis and management of venous thromboembolism. The Obstetrician and Gynaecologist 2007; 9: 3–8.
Asherson RA , Khamashta MA , Ordi-Ros J et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366–374.
Askie L , Duley L , Henderson-Smart D , Stewart L . Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. The Lancet 2007; 369: 1791–1798.
Askie LM , Duley L , Henderson-Smart DJ , Stewart LA . PARis Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 1791–1798.
Association of Anaesthetists of Great Britain and Ireland. Blood Transfusion and the Anaesthetist. London: Association of Anaesthetists; 2008.
Association of Anaesthetists of Great Britain and Ireland. Recommendations for Standards of Monitoring During Anaesthesia and Recovery. London: Association of Anaesthetists; 2007.
Atatoa-Carr P , Lennon D , Wilson N . Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline. New Zealand Medical Journal 2008; 121: 59–69.
Austin SK , Lambert J , Peebles D , Cohen H . Managing peri-delivery anticoagulation in women on therapeutic dose low molecular weight heparin : a role for unfractionated heparin? Journal of Thrombosis and Haemostasis 2007; 5: P-S-622.
Australian Institute of Health and Welfare . Rheumatic heart disease: all but forgotten in Australia except among Aboriginal and Torres Strait Islander peoples. Australian Institute of Health and Welfare: Australian Government 2004.
Avent N , Chitty LS . Non-invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound. Prenatal Diagnosis 2006; 26: 598–603.
Bach DS . Choice of prosthetic heart valves:update for the next generation. Journal of the American College of Cardiology 2003; 19; (10): 1717–1719.
Badawy SZ , Etman A , Singh M et al. Uterine artery embolization: the role in obstetrics and gynaecology. Clinical Imaging 2001; 25: 288–295.
Bain BJ . Blood Cells, 3rd edn. Oxford, UK: Blackwell Science, 1995.
Bais JM , Eskes M , Pel M , Bonsel GJ , Bleker OP . Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or = 500 ml) and severe (> or = 1000 ml) postpartum haemorrhage. European Journal of Obstetrics Gynecology Reproduction Biology 2004; 115: 166–172.
Bangerter M , Guthner C , Beneke H et al. Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies. European Journal of Haematology 2000; 65: 165–169.
Barbui T , Finazzi G. Myeloproliferative disease in pregnancy and other management issues. Hematology 2006; 1: 246–252.
Barker DJB (ed.) Foetal and Infant Origins of Adult Disease. London: BMJ Publishing Group, 1992.
Bates SM , Ginsberg JS . How we manage venous thromboembolism during pregnancy. Blood 2002; 100: 3470–8.
Bates SM , Greer IA , Hirsh J , Ginsberg JS . Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 627S–644S.
Bates SM , Greer IA , Pabinger I , Sofaer S , Hirsh J . Venous Thromboembolism, Thrombophilias, Anti-thrombotic therapy and Pregnancy. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn). Chest 2008; 133: 844S–886S.
Bates SM , Greer IA , Pabinger I et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn.). Chest 2008; 133: 844S–886S.
Bates SM , Greer IA , Pabinger I et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 844S–886S.
Bates SM , Greer IA , Pabinger I et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn). Chest 2008; 133: 844S–886S.
Bauersachs RM , Dudenhausen J , Faridi A et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thrombosis and Haemostasis 2007; 98: 1237–1245.
Beard J , Hillmen P , Anderson CC et al. Primary thrombocythaemia in pregnancy. British Journal of Haematology 1991; 77: 371–374.
Beilin Y , Arnold I , Hossain S . Evaluation of the platelet function analyzer (PFA-100®) vs. the thromboelastogram (TEG) in the parturient. International Journal of Obstetric Anesthesia 2006; 15: 7–12.
Bell WR , Braine HG , Ness PM , Kickler TS . Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. New England Journal of Medicine 1991; 325: 398–403.
Bellucci S , Janvier M , Tobelem G et al. Essential thrombocythemias. Clinical evolutionary and biological data. Cancer 1986; 58: 2440–2447.
Bennett PR , Le Van Kim C , Colin Y et al. Prenatal determination of fetal RhD type by DNA amplification. New England Journal of Medicine 1993; 329: 607–610.
Berends AL , de Groot CJM , Sijbrands EJ et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 2008; 51: 1034–1041.
Berkowitz RL , Kolb EA , McFarland JG et al. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstetrics and Gynecology 2006; 107: 91–96.
Blanco-Molina A , Trujillo-Santos J , Criado J et al. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thrombosis and Haemostasis 2007; 97: 186–190.
Boehlen F , Hohfeld P , Extermann P et al. Platelet count at term pregnancy: a reappraisal of the threshold. Obstetrics and Gynecology 2000; 95: 29–33.
Boehlen F , Hohlfeld P , Extermann P et al. Platelet count at term pregnancy: a reappraisal of the threshold. Obstetrics and Gynecology 2000; 95: 29–33.
Boffa MC , Lachassine E . Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus 2007; 16: 634–641.
Bolton-Maggs PH , Colvin BT , Satchi BT et al. Thrombogenic potential of factor XI concentrate. Lancet 1994; 344: 748–749.
Bolton-Maggs PH , Patterson DA , Wensley RT , Tuddenham EG . Definition of the bleeding tendency in factor XI-deficient kindred – a clinical and laboratory study. Thrombosis and Haemostasis 1995; 73: 194–202.
Bolton-Maggs PH , Perry DJ , Chalmers EA et al. The rare coagulation disorders–review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004; 10: 593–628.
Bolton-Maggs PH , Wan-Yin BY , McCraw AH et al. Inheritance and bleeding in factor XI deficiency. British Journal of Haematology 2008; 69: 521–528.
Bonnar J , McNicol GP , Douglas AS . Fibrinolytic enzyme system and pregnancy. British Medical Journal 1969; iii: 387–389.
Bonow RO , Carabello BA , Chatterjee K et al. focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008; 52: e1–142.
Brandt JT , Triplett DA , Alving B , Scharrer I . Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thrombosis and Haemostasis 1995; 74: 1185–1190.
Brenner B , Hoffman R , Blumenfeld Z , Weiner Z , Younis JS . Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thrombosis and Haemostasis 2000; 83: 693–697.
Brill-Edwards P , Ginsberg JS , Gent M et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in this Pregnancy Study Group. New England Journal of Medicine 2000; 343: 1439–1444.
British Committee for Standards in Haematology General Haematology task force . Guidelines for investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. British Journal of Haematology 2003; 120: 574–596.
British National Formulary 55 . London, BMJ Group and RPS Publishing, 2008.
British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group . British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58: 470–84.
Brown BJ , Heaston DK , Poulson AM et al. Uncontrollable postpartum bleeding: a new approach to hemostasis through angiographic arterial embolisation. Obstetrics and Gynaecology 1979; 54: 361–365.
Brunkhorst FM , Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine 2008; 358: 125–139.
Bunn F , Trivedi D , Ashraf S . Colloid solutions for fluid resuscitation. Cochrane Database System Review 2008 4: CD001319.
Burrows, R , Kelton J . Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstetrical and Gynecological Survey 1993; 48: 781–788.
Bussel JB , Berkowitz RL , Lynch L et al. Antenatal management of alloimmune thrombocytopenia with intravenous gammaglobulin: a randomized trial of the addition of low dose steroid to IVIg in fifty-five maternal–fetal pairs. American Journal of Obstetrics and Gynecology 1996; 174: 1414–1423.
Bustamente-Aragones A , Rodrguez de Alba M , Gonzalez-Gonzalez C et al. Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers. Haemophilia 2008; 14: 593–598.
Cadroy Y , Grandjean H , Pichon J et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. British Journal of Obstetrics and Gynaecology 1993;100: 416–420.
Callis L , Nieto J , Vila A , Rende J . Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity. Journal of Pediatrics 1980; 97: 653–656.
Candoni A , Fanin R , Michelutti T et al. Pregnancy and abortion in women with essential thrombocythemia. American Journal of Hematology 2002; 69: 233–234.
Cannegieter SC , Rosendaal FR , Briet E . Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635–641.
Caprioli J , Noris M , Brioschi S et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006; 108: 1267–1279.
Carapetis JR , Steer AC , Mulholland EK , Weber M . The global burden of group A streptococcal diseases. The Lancet Infectious Diseases. 2005; 5: 685–694.
Carlin AJ , Farquharson RG , Quenby SM et al. Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control. Human Reproduction 2004; 19: 1211–1214.
Casele H , Grobman WA . Cost-effectiveness of thromboprophylaxis with intermittent pneumatic compression at Cesarean delivery. Obstetrics and Gynecology 2006; 108: 535–540.
Castellá M , Pujol M , Juliá A et al. Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases. Vox Sanguinis 2004; 87: 287–290.
Catling SJ , Williams S , Fielding A . Cell salvage in obstetrics: an evaluation of ability of cell salvage combined with leucocyte depletion filter to remove amniotic fluid from operative blood loss at caesarean section. International Journal of Obstetric Anesthesia 1999; 8: 79–84.
CEMACH Report 2000–2002(Why Mothers Die). (www.cemach.org.uk)
CEMACH Report 2003–2005(Saving Mothers' Lives). (www.cemach.org.uk)
CEMACH. Saving Mother's Lives: Reviewing maternal deaths to make motherhood safer – 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom DoH 2007.
Centrone AL , Freda RN , McGowan L . Polycythemia rubra vera in pregnancy. Obstetrics and Gynecology 1967; 30: 657–659.
Cervera R , Asherson RA , Font J et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic and immmunolgic characteristics of 50 patients from our clinics and recent literature. Medicine 1997; 76(3): 203–212.
Cervera R , Piette JC , Font J et al. Euro-Phospholipids Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis and Rheumatism 2002; 46: 1019–1027.
Chan WS , Anand S , Ginsberg JS . Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Archives of Internal Medicine 2000; 160: 191–196.
Chappell LC , Seed PT , Briley A et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. American Journal of Obstetrics and Gynecology 2002; 187:127–136.
Chelmow D. Postpartum haemorrhage: prevention. British Medical Journal Clinical Evidence 2007; 2:1410.
Chemaitilly W , Mertens AC , Mitby P et al. Acute ovarian failure in the Childhood Cancer Survivor Study. Journal of Clinical Endocrinology and Metabolism 2006; 91: 1723–1728.
Chi C , Lee CA , Shitagh N et al. Pregnancy in carriers of haemophilia. Haemophilia 2008; 14: 56–64.
Chitty LS , van der Schoot , Hahn S , Avent ND . SAFE – The special non-invasive advances in fetal and neonatal evaluation network: aims and achievements. Prenatal Diagnosis 2008; 28: 83–88.
Christiaens GC , Niewenhuis HK , Bussel JB . Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstetrics and Gynecology 1997; 90: 546–552.
Christopoulos C , Dimakopoulou V , Rotas E . Primary ovarian insufficiency associated with imatinib therapy. New England Journal of Medicine 2008; 358: 1079–1080.
Cincotta R , Higgins JR , Tippett C et al. Managament of essential thrombocythaemia during pregnancy. Australia and New Zealand Journal of Obstetrics and Gynaecology 2000; 40: 33–37.
Clark P , Brennand J , Conkie JA et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thrombosis and Haemostasis 1998; 79: 1166–1170.
CLASP (Collaborative Low dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619–629.
CLASP : a randomised trial of low dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative low dose Aspirin Study in Pregnancy) Collaborative Group. The Lancet 1994; 343: 619–629.
Confidential Enquiry into Maternal and Child Health . Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer, 2003–5. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London, RCOG Press, 2007.
Conti M , Mari D , Conti E et al. Pregnancy in women with different types of von Willebrand disease. Obstetrics and Gynaecology 1986; 68: 282–285.
Cook JV , Kyriou J . Radiation from CT and perfusion scanning in pregnancy. British Medical Journal 2005; 331: 350.
Cortes-Hernandez J , Ordi-Ros J , Paredes F et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford). 2002; 41: 643–650.
Cotrufo M , De Feo M , De Santo LS et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obstetrics and Gynecology 2002; 99: 35–40.
Cowchock FS , Reece EA , Balaban D et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomised trial comparing prednisone with low-dose heparin treatment. American Journal of Obstetrics and Gynaeology 2003 101; 1319–1332.
Critchley HO , Wallace WH , Shalet SM et al. Abdominal irradiation in childhood: the potential for pregnancy. British Journal of Obstetrics and Gynaecology. 1992; 97: 804–810.
Crowley JP , Barcohana Y , Sturner WQ . Disseminated intravascular coagulation following first trimester abortion in polycythemia vera. Increased platelet count apparently contributed to fatal outcome. Rhode Island Medical Journal 1987; 70: 109–112.
Crowther C , Middleton P . Anti-D administration after childbirth for preventing Rhesus alloimmunisation. Cochrane Database of Systematic Reviews 1997 (2) CD000021.
Dale DC , Cottle TE , Fier CJ et al. Severe chronic neutropenia: treatment and follow-up of patients in the severe chronic neutropenia international registry. American Journal of Hematology 2003; 72: 82–93.
Daniels G , Finning K , Martin P , Summers J . Fetal blood group genotyping. Present and future. Annals of The New York Academy Science 2006; 1075: 88–95.
Dann EJ , Epelbaum R , Avivi I et al. Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma. Human Reproduction 2005;20; 2247–2249.
Davies JR , Roshan F , Hallworth SP . Hemostatic function in healthy pregnant and preeclamptic women: an assessment using the platelet function analyzer (PFA-100®) and Thromboelastograph® . Anesthesia and Analgesia 2007; 104: 416–420.
Davies L , Brown TJ , Haynes S , Payne K , Elliott RA , McCollum C . Cost effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technology Assessment 2006; 10: 1–228.
De Caterina R , Husted S , Wallentin L et al. Anticoagulants in heart disease: current status and perspectives [see comment]. European Heart Journal 2007; 28: 880–913.
De Stefano V , Martinelli I , Rossi E et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. British Journal of Haematology 2006; 135: 386–391.
Deol PS , Barnes TA , Dampier K , Pasi KJ , Oppenheimer C , Pavord SR . The effects of folic acid supplements on coagulation status in pregnancy. British Journal of Haematology 2004; 127: 204–208.
Descargues G , Mauger Tinlot F et al. Menses, fertility and pregnancy after arterial embolization for the control of postpartum haemorrhage. Human Reproduction 2004; 19: 339–343.
Di Nisio M , Peters L , Middeldorp S . Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database of Systematic Reviews 2005;(2):CD004734.
Dieter RS , Dieter RA, Jr ., Dieter RA, 3rd et al. Prosthetic heart valve thrombosis: an overview. Wisconsin Medical Journal 2002; 101: 67–69.
Dirkmann D , Hanke AA , Gorlinger K , Peters J . Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesthesia and Analgesia 2008; 106: 1627–1632.
Diz-Küçükkaya R , Hacihanefioglu A , Yenerel M et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 2001; 98: 1760–1764.
Dodd J , Dare MR , Middleton P . Treatment for women with postpartum iron deficiency anaemia. Cochrane Database of Systematic Reviews 2004; 4: CD004222.
DoH . Why Mothers Die, 1997–1999. The Fifth Annual Report of the Confidential Enquiries in to Maternal Deaths in the United Kingdom. DoH RCOG Press London.
Doumouchtis SK , Papageorgiou AT , Arulkumaran S . Systematic review of conservative management of postpartum haemorrhage: what to do when medical treatment fails. Obstetrical and Gynaecological Survey 2007; 68: 540–547.
Doyle LW , Crowther CA , Middleton P et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Systems Review 2009; 1: CD004661.
Dreyfus M , Hedelin G , Kutnahorsky R et al. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstetrics and Gynecology 2001; 97: 29–34.
Dubois J , Garel L , Grignon A et al. Placenta percreta: balloon occlusion and embolization of the internal iliac arteries to reduce intra-operative blood losses. American Journal of Obstetrics and Gynaecology 1997; 176: 723–726.
Ducloy-Bouthors AS , Caron C , Subtil D et al. Thrombotic thrombocytopenic purpura: medical and biological monitoring of six pregnancies. European Journal of Obstetrics and Gynecology Reproduction Biology 2003; 111: 146–152.
EA., Letsky . Haemostasis and epidural anaesthesia. International Journal of Obstetric Anesthesia. 1991; 1: 51–54.
Edlestam G , Lowbeer C , Kral G et al. New reference values for routine blood samples and human neutrophilic lipocalin during third trimester pregnancy. Scandinavian Journal of Clinical Laboratory Investigation 2001; 61: 583–592.
Elliott MA , Tefferi A . Thrombocythaemia and pregnancy. Best Practice Research Clinical Haematology 2003; 16: 227–242.
Empson M , Lassere M , Craig J , Scott J . Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews 2005; 002859.
Ezra Y , Rose M , Eldor A . Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: a clinical study of 16 pregnancies. American Journal of Hematology 1996; 51: 1–6.
Farquharson RG , Quenby S , Greaves M . Antiphospholipid syndrome in pregnancy: a randomised controlled trial of treatment. Obstetrics and Gynecology 2002; 100: 408–413.
Fay RA , Hughes AO , Farron NT . Platelets in pregnancy: hyperdestruction in pregnancy. Obstetrics and Gynecology 1983; 61: 238–240.
Ferguson A.D. , Hebert C.P.A , Mazer C.D et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. The BART study. New England Journal of Medicine 2008; 358: 2319–2331.
Finning K , Martin P , Summers J et al. Effect of high-throughput RHD typing of fetal DNA in maternal plasma: on use of anti-RHD immunoglobulin in RHD negative pregnant women: prospective feasibility study. British Medical Journal 2008; 336: 816–818.
Fishbane S , Ungureanu VD , Maesaka JK et al. The safety of intravenous iron dextran in hemodialysis patients. American Journal of Kidney Disease 1996; 28: 529–534.
Fonseca JE , Mendez F , Catano C , Arias F . Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. American Journal of Obstetrics and Gynecology 2005; 193: 1591–1598.
Ford JB , Roberts CL , Simpson JM , Vaughan J , Cameron CA . Increased postpartum hemorrhage rates in Australia. International Journal of Gynaecology and Obstetrics (the official organ of the International Federation of Gynaecology and Obstetrics) 2007; 98, 237–243.
Foster PA . The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thrombosis and Haemostasis 1995; 74: 784–790.
Freckman HA , Fry HL , Mendez FL et al. Chlorambucil–prednisolone therapy for disseminated breast carcinoma. Journal of the American Medical Society 1964; 189: 23–26.
Galli M , Luciani D , Bertolini G , Barbui T . Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827–1832.
Gates S , Brocklehurst P , Davis LJ . Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Systematic Review 2002; (2):CD001689.
Gelson E , Johnson M , Gatzoulis M , Uebing A. Cardiac Disease in Pregnancy Part 2 : Acquired Heart Disease. The Obstetrician and Gynaecologist 2007; 9: 83–87.
Giacalone PL , Vignal J , Daures JP et al. A randomised evaluation of two techniques of management of the third stage of labour in women at low risk of postpartum haemorrhage. British Journal of Obstetrics and Gynaecology 2000; 107: 396–400.
Gilbert JS , Babcock SA , Granger JP . Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 2007; 50: 1142–1147.
Gill JC , Endres-Brooks J , Bauer PJ et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691–1695.
Gill KK , Kelton JG . Management of idiopathic thrombocytopenic purpura in pregnancy. Seminars in Hematology 2000; 37: 275–289.
Girardi G , Redecha P , Salmon JE . Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nature Med. 2004; 10: 1222–1226.
Goodeve A , Eikenboom J , Castaman G et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109: 112–121.
Gotic M , Cvetkovic M , Bozanovic T , Cemerikic V . [Successful treatment of primary myelofibrosis with thrombocytosis during pregnancy with alfa-interferon] Srp Arh Celok Lek 2001; 129: 304–308.
Green DM , Whitton JA , Stovall M et al. Pregnancy outcomes in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. American Journal of Obstetrics and Gynecology 2002; 187: 1070–1080.
Green PM , Saad S , Lewis CM , Gianelli F . Mutation rates in humans I: overall and sex-specific rates obtained from a population study of haemophilia B. American Journal of Human Genetics 1999; 65: 1572–1579.
Greer I , Hunt BJ . Low molecular weight heparin in pregnancy: current issues. British Journal of Haematology 2005; 128: 593–60.
Greer IA , Nelson-Piercy C . Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106: 401–407.
Greer IA , Nelson-Piercy C . Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106: 401–7.
Griesshammer M , Struve S , Harrison CM . Essential thrombocythemia/polycythemia vera and pregnancy: the need for an observational study in Europe. Seminars in Thrombosis and Hemostasis 2006; 32: 422–429.
Gris JC , Mercier E , Quere I et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004; 103: 3695–3699.
Hall JG , Pauli RM , Wilson KM . Maternal and fetal sequelae of anticoagulation during pregnancy. American Journal of Medicine 1980; 68: 122–138.
Hancock JF , Wieland K , Pugh RE et al. A molecular genetic study of factor XI deficiency. Blood 1991; 77: 1942–1948.
Hansch E , Chitkara U , McAlpine J et al. Pelvic arterial embolization for control of obstetric hemorrhage: a five year experience. American Journal of Obstetrics and Gynaecology 1999; 180:1454–1460.
Harris EN , Pierangeli SS . Revisiting the anticardiolipin test and its standardization. Lupus 2002; 11: 269–275.
Harris RE , Conrad FG . Polycythemia vera in the childbearing age. Archives of Internal Medicine 1967; 120: 697–700.
Harrison CN . Platelets and thrombosis in myeloproliferative diseases. Hematology 2005; 1: 409–415.
Haverkate F , Samama M . Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thrombosis and Haemostasis 1995; 73: 151–161.
Haynes J , Laffan M , Plaat F . Use of recombinant activated factor VII in massive obstetric haemorrhage. International Journal of Obstetrics and Anesthesia 2007; 16: 40–49.
Hayward CP , Sutton DM , Carter WH , Jr. et al. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Archives in Internal Medicine 1994; 154: 982–987.
Heit JA , Kobbervig CE , James AH , Petterson TM , Bailey KR , Melton LJ 3rd . Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Annals of Internal Medicine 2005; 143: 697–706.
Henry DA , Carless PA , Moxey AJ et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2007; 17: CD001886.
Hochman A , Stein JA . Polycythemia and pregnancy. Report of a case. Obstetrics and Gynecology 1961; 18: 230–235.
Holm K , Nysom K , Brocks V et al. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation. Bone Marrow Transplantation. 1999; 23: 259–263.
Honein MA , Paulozzi LJ , Mathews TJ et al. Impact of folic acid food fortification of the food supply on the occurrence of neural tube defects. Journal of the American Medical Association, 2001; 285: 2981–2986.
Horlocker TT , Wedel DJ , Benzon H et al. Regional anesthesia in the anticoagulated patient: defining the risks. (The Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation.) Regional Anesthesia and Pain Medicine 2003; 23: 172–197
Howard RJ , Tuck SM , Pearson TC . Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome. British Journal of Obstetrics and Gynaecology 1995; 102: 947–951.
Huppetz B . Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008; 51: 970–975.
Investigation into 10 maternal deaths at, or following delivery at, Northwick Park Hospital, North West London NHS Trust, between April 2002 and April 2005. London: Healthcare Commission, 2006.
Irgens HU , Reisaeter L , Irgens LM , Lie RT . Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. British Medical Journal 2001; 323: 1213–1217.
ISTH. SSC VWF Database [Database on the Internet]. Sheffield, UK: University of Sheffield. http://www.vwf.group.shef.ac.uk/index.html (Accessed 23.01.2008).
Jabara S , Barnhart KT . Is Rh immune globulin needed in early first-trimester abortion? A review. American Journal of Obstetrics and Gynecology 2003; 188: 623–627.
Jackson JC . Adverse events associated with exchange transfusion in healthy and ill newborns. Paediatrics 1997; 99: E7.
Jacobsen AF , Skjeldestad FE , Sandset PM . Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. Journal of Thrombosis and Haemostasis 2008; 6: 905–12.
Jacobsen AF , Skjeldestad FE , Sandset PM . Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. Journal of Thrombosis and Haemostasis 2008; 6: 905–912.
James AH , Abel DE , Braucazio LR . Anticoagulants in pregnancy. Obstetrical and Gynaecological Survey 2005; 61: 59–61.
James AH , Brancazio LR , Gehrig TR et al. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. Journal of Maternal–Fetal and Neonatal Medicine 2006; 19: 543–549.
James AH , Jamison MG , Brancazio LR , Myers ER . Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. American Journal of Obstetrics and Gynecology 2006; 194: 1311–5.
James AH , Jamison MG , Brancazio LR , Myers ER . Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. American Journal of Obstetrics and Gynecology 2006; 194: 1311–5.
James AH , Jamison MG . Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. Journal of Thrombosis and Haemostasis 2007; 5: 1165–1169.
James AH , Tapson VF , Goldhaber SZ . Thrombosis during pregnancy and the postpartum period. American Journal of Obstetrics and Gynecology 2005; 193: 216–219.
James AH . Prevention and management of venous thromboembolism in pregnancy. American Journal of Medicine 2007; 120: S26–S34.
James AH . Prevention and management of venous thromboembolism in pregnancy. American Journal of Medicine 2007; 120: S26–S34.
Jensen CE , Tuck SM , Wonke B . Fertility in β Thalassemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature. British Journal of Obstetrics and Gynaecology 1995; 102: 625–629.
JG Ray , R Boskovic , B Knie et al. In vitro analysis of human transplacental transport of desmopressin. Clinical Biochemistry 2004; 37: 10–13.
Johnston JA , Brill-Edwards P , Ginsberg JS et al. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism. American Journal of Medicine 2005; 118: 503–514.
Kadir R , Chi C , Bolton-Maggs P . Pregnancy and rare bleeding disorders. Haemophilia 2009; 15: 990–1005.
Kadir RA , Economides DL , Braithwaite J et al. The obstetric experience of carriers of haemophilia. British Journal of Obstetrcs and Gynaecology 1997; 104: 803–810.
Kadir RA , Lee CA , Sabin CA , Pollard D , Economides DL . Pregnancy in women with von Willebrand's disease or factor XI deficiency. British Journal of Obstetrics and Gynaecology 1998; 105: 314–321.
Kadir RA , Lee CA , Sabin CA et al. Pregnancy in women with von Willebrand's disease or factor XI deficiency. British Journal of Obstetrics and Gynaecology 1998; 105: 314–321.
Kaplan C . Neonatal alloimmune thrombocytopenia: a 50 year story. Immunohematology 2007; 23: 9–13.
Kasper CK , Lin JC . Prevalence of sporadic and familial haemophilia. Haemophilia 2007; 13: 90–92.
Kawamata K , Neki R , Yamanaka K et al. Risks and pregnancy outcome in women with prosthetic mechanical heart valve replacement. Circulation Journal 2007; 71: 211–213.
Kerr A , Trambert J , Mikhail M et al. Preoperative transcatheter embolization of abdominal pregnancy: report of three cases. Journal of Vascular and Interventional Radiology 1993; 4: 733–735.
Khan GQ , John IS , Wani S et al. Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomised controlled trial. American Journal of Obstetrics and Gynecology 1997; 177: 770–774.
Khan KS , Wojdyla D , Say L , Gulmezoglu AM , van Look PF. WHO analysis of causes of maternal death: a systematic review. The Lancet 2006; 367: 1066–1074.
Knight M , UKOSS . Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. British Journal of Obstetrics and Gynecology: an International Journal of Obstetrics and Gynaecology, 2007; 114, 1380–1387.
Knight M ; on behalf of UKOSS. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG: An International Journal of Obstetrics & Gynaecology 2008; 115: 453–461.
Knight M on behalf of UKOSS . Antenatal pulmonary embolism: risk factors, management and outcomes. British Journal of Obstetrics and Gynecology 2008; 115: 453–461.
Kobayashi T , Kanayama N , Tokunaga N et al. Prenatal and peripartum management of congenital afibrinogenaemia. British Journal of Haematology 2000; 109: 364–366.
Koshy M , Burd L , Wallace D et al. Prophylactic red cell transfusion in pregnant patients with sickle cell disease. A randomized cooperative study. New England Journal of Medicine 1988; 319: 1447–1452.
Koyama H , Wada T , Nishizawa Y et al. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 1977; 39: 1403–1409.
Kulkarni, Roshni and Lusher, Jeanne M. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. Journal of Pediatric Hematology/Oncology 1999; 21: 289–295.
Kumpel BM . Efficacy of RhD monoclonal antibodies in clinical trails as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers. Vox Sanguinis 2007; 93: 99–111.
Kutteh WH . Antiphospholipid antibody associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low dose aspirin alone. American Journal of Obstetrics and Gynaecology 1996; 174: 1584–1589.
Lalonde A , Daviss BA , Acosta A , Herschderfer K . Postpartum hemorrhage today: ICM/FIGO initiative 2004–2006. International Journal of Gynaecology and Obstetrics 2006; 94: 243–253.
Larsen TB , Sorensen HT , Gislum M , Johnsen SP . Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study. Thrombosis Research 2007; 120: 505–509.
Le Thi Huong D , Weschler B , Vauthier-Brouzes et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosis and/or the antiphospholipid syndrome. Rheumatology 2006; 45: 332–338.
Lee CA , Chi C , Pavord SR et al. UK haemophilia Center Doctors' Organization. The obstetric and gynaecological management of women with inherited bleeding disorders – review with guidelines produced by a taskforce of UK Haemophilia Center Doctors' Organisation. Haemophilia 2006; 12: 301–336.
Lee CA , Chi C , Pavord SR et al. UK haemophilia Centre Doctors' Organization. The obstetric and gynaecological management of women with inherited bleeding disorders – review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' organization. Haemophilia 2006; 12: 301–336.
Lee JH , Park NH , Keum DY et al. Low molecular weight heparin treatment in pregnant women with a mechanical heart valve prosthesis. Journal of Korean Medical Science 2007; 22: 258–261.
Lengyel M , Horstkotte D , Voller H , Mistiaen WP , Working Group Infection Thrombosis, Embolism and Bleeding of the Society of Heart Valve Disease. Recommendations for the management of prosthetic valve thrombosis. Journal of Heart Valve Disease 2005; 14: 567–575.
Leone G , De S, V , D'Addosio A . [Essential thrombocythemia pregnancy]: Haematologica 1991; 76: 365–367.
Leonhardt G , Gaul C , Nietsch HH et al. Thrombolytic therapy in pregnancy. Journal of Thrombosis and Thrombolysis 2006; 21: 271–276.
Leonhardt G , Gaul C , Nietsch HH et al. Thrombolytic therapy in pregnancy. Journal of Thrombosis and Thrombolysis 2006; 21: 271–276.
Leuger M , Oldenburg J Lavergne J-M et al. Somatic mosaicism in Haemophilia A: a fairly common event. American Journal of Human Genetics 2001; 69: 75–87.
Levi M , Peters M , Buller HR . Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Critical Care Medicine 2005; 33: 883–890.
Levine AB , Agarwal R , Seckl MJ et al. Placenta accreta: comparison of cases managed with and without pelvic artery balloon catheters. Journal of Maternal and Fetal Medicine 1999; 8: 173–176.
Levine RJ , Lam C , Qian C et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New England and Journal of Medicine 2006; 355: 992–1005.
Lewis G (Ed.). Saving Mothers' Lives : reviewing maternal deaths to make motherhood safer 2003–2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London, CEMACH, 2007.
Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). Why mothers die (2000–2002), 2005; London: CEMACH.
Lewis, G (ed). The Confidential Enquiry into Maternal and Child Health. (CEMACH). Saving Mothers; Lives: reviewing maternal deaths to make motherhood safer 2003–2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom, 2007.
Lewis, G. ed. The Confidential Enquiry into Maternal and Child Health. Saving mothers' lives: reviewing maternal deaths to make motherhood safer 2003–2005. The seventh report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH, 2007.
Li B , Ogasawara AK , Yang R et al. KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF. Hypertension 2002; 39: 1095–1100.
Lindqvist P , Dahlbäck B , Marŝál K . Thrombotic risk during pregnancy: a population study. Obstetrics and Gynecology. 1999; 94: 595–599.
Lindqvist P , Dahlbäck B , Marŝál K. Thrombotic risk during pregnancy: a population study. Obstetrics and Gynecology 1999; 94: 595–9.
Lo YMD , Corbetta N , Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485–487.
Lobel SM , Meyetovitz MF , Benson CC et al. Preoperative angiographic uterine artery embolization in the management of cervical pregnancy. Obstetrics and Gynaecology 1990; 76: 938–941.
Loo CC , Dahlgren G , Irestedt L . Neurological complications of obstetric regional analgesia. International Journal of Obstetric Anesthesia 2000; 9: 99–124.
Lu F , Longo M , Tamayo E et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. American Journal of Obstetrics and Gynecology 2007; 196: 396.
Ludlam CA , Pasi KJ , Bolton-Maggs P et al. A framework for genetic service provision for haemophilia and other inherited bleeding disorders. Haemophilia 2005; 11: 145–163.
Magann EF , Evans S , Chauhan SP , Lanneua G , Fisk AD , Morrison JC . The length of the third stage of labor and risk of postpartum hemorrhage. Obstetrics and Gynecology 2005; 105(2): 290–293.
Magann EF , Evans S , Hutchinson M et al. Postpartum hemorrhage after cesarean delivery; an analysis of risk factors. South Medical Journal 2005; 98: 681–685.
Magda M Megahed, IM Taher. Folate and homocysteine levels in pregnancy. British Journal of Biomedical Science 2004; 62: 84–86.
Magnussen EB , Vatlen LJ , Lund-Nilsen TI , Salvesen KA , Smith GD , Romundstad PR . Pregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. British Medical Journal 2007; 225: 978–981.
Mak A , Cheung MWL , Cheak AA , Ho RC . Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology 2010; 49: 281–288.
Maki M , Kobayashi T , Terao T et al. Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group. Thrombosis and Haemostasis 2000; 84: 583–590.
Manfredi E , van Zaane B , Gerdes VE et al. Hypothyroidism and acquired von Willebrand's syndrome: a systematic review. Haemophilia 2008; 14: 423–433.
Mannucci PM , Tenconi PM , Castaman G , Rodeghiero F . Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial. Blood 1992; 79: 3130–3137.
Mannucci PM . Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women. Blood 2005; 105: 3382.
Mari G , Deter RL Carpenter RL et al. For the collaborative group for the assessment of the blood velocity in anaemic fetuses. Non-invasive diagnosis by Doppler ultrasonography of fetal anaemia due to maternal red-cell alloimmunisation. New England Journal of Medicine 2000; 342: 9–14.
Masuyama H , Nakatsukasa H , Takamoto N , Hiramatsu Y . Correlation between soluble endoglin, vascular endothelial growth factor receptor-1 and adipocytokines in preeclampsia. Journal of Clinical and Endocrinological Metabolism 2007; 92: 2672–2679.
Matchaba P , Moodley J . Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst. Rev. 2004; (1): CD 002076.
Maybury H J , Waugh J J S , Gornall A , Pavord S . There is a return to non-pregnant coagulation parameters after four not six weeks postpartum following spontaneous vaginal delivery. Obstetric Medicine 2008; 1: 92–94.
Maybury HJ , Waugh JJS , Gornall A , Pavord S . There is a return to non-pregnant coagulation parameters after four not six weeks postpartum following spontaneous vaginal delivery. Obstetric Medicine 2008; 1: 92–94.
Maynard SE , Min JY , Mercham J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Journal of Clinical Investigations 2003; 111: 649–658.
McColl D , Ellison J , Greer IA. et al. Prevalence of the post thrombotic syndrome in young women with previous venous thromboembolism. British Journal of Haematology 2000; 108: 272–274.
McCoy S , Baldwin K . Pharmacotherapeutic options for the treatment of preeclampsia. American Journal Health Systems Pharm. 2009; 66: 337–344.
McLintock C , North RA , White HD . Prosthetic heart valves and pregnancy. Circulation 2003; 108: e159–60.
McMorrow RC , Ryan SM , Blunnie WP et al. Use of recombinant factor VIIa in massive post-partum haemorrhage. European Journal of Anaesthesiology 2008; 7: 1–6.
McMullin MF , Bareford D , Campbell P et al. Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. British Journal of Haematology 2005; 130: 174–195.
Meirow D , Baum M , Yaron R et al. Ovarian tissue cryopreservation in hematologic malignancy: ten years' experience. Leukemia and Lymphoma 2007; 48: 1569–1576.
Meirow D , Dor J . Epidemiology and infertility in cancer patients. In Preservation of Fertility, Tulandi T and Gosden RG , ed. Taylor & Francis. 2004.
Meirow D. Reproduction post-chemotherapy in young cancer patients. Molecular Cell Endocrinology 2000; 169:123–131.
Meirow D. Reproduction post-chemotherapy in young cancer patients. Molecular Cell Endocrinology. 2000; 169: 123–131.
Mello G , Parretti E , Fatini C et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 2005; 45: 86–91.
Meschengieser SS , Fondevila CG , Santarelli MT , Lazzari MA . Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 1999; 82: 23–26.
Michaelidis K , Tuddenham EG , Turner C et al. Live birth following the first mutation specific pre-implantation genetic diagnosis for haemophilia A. Thrombosis and Haemostasis 2006; 95: 373–379.
Michel M , Novoa MV Bussel JB . Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy. British Journal of Haematology 2003; 123: 142–146.
Milman N , Bergholt T , Byg K-E et al. Reference intervals for haematological variables during normal pregnancy and postpartum in 434 healthy Danish women. European Journal of Haematology 2007; 79: 39–46.
Mitty HA , Sterling KM , Alvarez M et al. Obstetric hemorrhage: prophylactic and emergency arterial catheterisation and embolotherapy. Radiology 1993; 188: 183–187.
Miyakis S , Lockshin MD , Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis 2006; 4: 295–306.
Modell B , Harris R , Lane B et al. Informed consent in genetic screening for thalassemia during pregnancy: audit from a national confidental inquiry. British Medical Journal 2000; 320: 337–341.
Mousa HA , Downey C , Alfirevic Z , Toh C-H . Thrombin activatable fibrinolysis inhibitor and its fibrinolytic effect in normal pregnancy. Thrombosis and Haemostasis 2004; 92: 1025–1031.
Murphy MF , Bussel JB . Advances in the management of alloimmune thrombocytopenia. British Journal of Haematology 2007; 136: 366–378.
Murphy MF , Williamson LM , Urbaniak SJ . Antenatal screening for fetomaternal alloimmune thrombocytopenia: should we be doing it? Vox Sanguinis 2002; 83: 409–16.
Murphy MM , Molloy A , Ueland PM et al. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. The Journal of Nutrition 2007; 137: 1863–1866.
Myers B , Pavord S , Kean L et al. Pregnancy outcome in Factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with Factor XI deficiency. British Journal of Obstetrics and Gynaecology: an International Journal of Obstetrics and Gynaecology 2007; 114: 643–646.
Nassar AH , Hobeika EM , Abd Essamad HM et al. Usta IM . Pregnancy outcome in women with prosthetic heart valves. American Journal of Obstetrics and Gynecology 2004; 191: 1009–1013.
National Institute for Clinical Excellence . Ultrasound Locating Devices for Placing Central Venous Catheters. Guideline number 49. London: NICE; 2002.
National Institute for Clinical Excellence . Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women. Technology Appraisal Guidance no. 41. www.nice.org.uk, 2002.
Nelson SM , Greer IA . Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium. Obstetric Gynecologic Clinics of North America 2006; 33: 413–427.
NICE clinical guideline 50. Acutely ill patients in hospital. July 2007.
Nicolaides KH , Soothill PW , Clewell W , Rodeck CH . Rh disease: intravascular fetal blood transfusion by cordocentesis. Fetal Therapy 1986; 1: 185–192.
Nielson LK , Green TH , Sandlie I et al. In vitro assessment of recombinant, mutant anti-D immunoglobulin G devoid of haemolytic activity for treatment of on-going haemolytic disease of the fetus and newborn, Transfusion 2008; 48: 12–19.
Niittyvuopio R , Juvonen E , Kaaja R et al. Pregnancy in essential thrombocythaemia: experience with 40 pregnancies. European Journal of Haematology 2004; 73: 434–436.
Oktay K , Cil AP , Bang H et al. Efficiency of oocyte cryopreservation: a meta-analysis. Fertility and Sterility 2006; 86: 70–80.
Oran B , Lee-Parritz A , Ansell J . Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thrombosis and Haemostasis 2004; 92: 747–751.
Ornan D , White R , Pollak J et al. Pelvic embolization for intractable postpartum hemorrhage: long-term follow-up and implications for fertility. Obstetrics and Gynecology 2003; 102: 904–910.
Ouwehand WH , Stafford P , Ghevaert C et al. Platelet immunology, present and future. ISBT Science Series 2006; 1: 96–102.
Pagliaro P , Arrigoni L , Muggiasca ML et al. Primary thrombocythemia and prgnancy: treatment and outcome in fifteen cases. American Journal of Hematology 1996; 53: 6–10.
Papageorgiou AT , Yu CK , Bindra R , Pandis G , Nicolaides KH . Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks' of gestation. Ultrasound Obstetrics and Gynecology 2001; 18: 441–449.
Pasi KJ , Collins PW , Keeling DM et al. Management of von Willebrand disease: a guideline from the UK Haemophilia Center Doctors' Organization. Haemophilia 2004; 10: 218–231.
Pata O , Tok CE , Yazici G et al. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester. American Journal of Perinatology 2004; 21: 135–137.
Pearl ML , Braga CA . Percutaneous transcatheter embolization for control of life-threatening pelvic hemorrhage from gestational trophoblastic disease. Obstetrics and Gynaecology 1992; 80: 571–574.
Pena Rossa JP , Viteri FE . Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database of Systematic Reviews 2006; 3: CD004736.
Penney G , Adamson L . Scottish Confidential Audit of Severe Maternal Morbidity 4th Annual Report 2006 SPCERH.
Pereira L , Jenkins TM , Berghella V . Conventional management of maternal red cell alloimmunisation compared with management by Doppler assessment of middle cerebral artery peak systolic velocity. American Journal of Obstetrics and Gynecology 2003; 189: 1002–1006.
Perel P , Roberts I . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Systematics Reviews 2007; 17: CD000567.
Plug I , Mauser-Bunschoten EP , Broker-Vriends AH et al. Bleeding in carriers of haemophilia. Blood 2006; 108: 52–56.
Powars DR . Natural history of sickle cell disease: the first 10 years. Seminars in Haematology 1975; 12: 267–285.
Prendiville WJ , Elbourne D , McDonald S . Active versus expectant management of the third stage of labour. Cochrane Database System Review 2000(2): CD00007.
Preston FE , Rosendaal FR , Walker ID et al. Increased fetal loss in women with heritable thrombophilia.[comment]. The Lancet 1996; 348: 913–916.
Provan D , Stasi R , Newland AC . International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115: 168–186.
Pye S , Cortes J , Ault P et al. The effects of imatinib on pregnancy outcome. Blood 2008; 111: 5505–5508.
Radder CM , Brand A , Kanhai HH . Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sanguinis 2003; 84: 318–325.
Radder CM , Brand A , Kanhai HHH . A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. American Journal of Obstetrics and Gynecology 2001; 185: 683–688.
Rahimy MC , Gango A , Adjou R et al. Effect of active prenatal management on pregnancy outcome in sickle cell disease in African setting. Blood 2000; 96: 1685–1689.
Rai R , Cohen H , Dave M , Regan L . Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. British Medical Journal 1997; 314: 253–257.
Rai RS , Clifford K , Cohen H , Regan L . High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Human Reproduction 1995; 10: 3301–3304.
Ramsahoye BH , Davies SV , Dasani H , Person JF . Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Haemophilia 1885; 1: 140–144.
Randi ML , Rossi C , Fabris F , Girolami A . Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies. Journal of Internal Medicine 1999; 246: 517–518.
Rasmussen S , Irgens LM . History of fetal growth restriction is more strongly associated with severe rather than milder pregnancy-induced hypertension. Hypertension 2008; 51: 1231–1238.
Rath W , Faridi A , Dudenhausen JW . HELLP syndrome. Journal of Perinatal Medicine 2000; 28: 249–260.
Rayment R , Brunskill SJ , Stanworth S et al. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. The Cochrane Library, Issue 1, 2005. Chichester, UK: John Wiley & Sons, Ltd.
Redman CW , Sacks GP , Sargent IL . Preeclampsia: an excessive maternal inflammatory response to pregnancy. American Journal of Obstetrics and Gynecology 1999; 180: 499–506.
Reveiz L , Gyte GML , Cuervo LG . Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database of Systematic Reviews 2001; 2: CD003094.
Rey E , Kahn SR , David M , Shrier I . Thrombophilic disorders and fetal loss: a meta-analysis. The Lancet 2003; 361: 901–908.
Ridolfi RL , Bell WR . Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) 1981; 60: 413–428.
Riely CA . Acute fatty liver of pregnancy. Seminars Liver Disease 1987; 7: 47–54.
Roberts JM , Gammill HS . Preeclampsia: recent insights. Hypertension 2005; 46: 1243–1249.
Robertson L , Wu O , Langhorne P et al. Thrombophilia in pregnancy: a systematic review. British Journal of Haematology 2006; 132: 171–196.
Robertson, L. and Wu, O. and Langhorne, P. and Twaddle, S. and Clark, P. and Lowe, G.D.O. and Walker, I.D. and Greaves, M. and Brenkel, I. and Regan, L. and Greer, I.A. Thrombophilia in pregnancy: a systematic review. British Journal of Haematology 2006; 132: 171–196.
Robinson S , Bewley S , Hunt BJ , Radia DH , Harrison CN . The management and outcome of 18 pregnancies in women with polycythemia vera. Haematologica 2005; 90: 1477–1483.
Robinson S , Bewley S , Hunt BJ et al. The management and outcome of 18 pregnancies in women with polycythemia vera. Haematologica 2005; 90; 1477–1483.
Ronsmans C , Graham WJ ; Maternal mortality: who, when, where, and why? Lancet Maternal Survival Series steering group. Lancet 2006; 368: 1189–1200.
Roque H , Funai E , Lockwood CJ . von Willebrand disease and pregnancy. The Journal of Maternal–Fetal Medicine. 2000; 9: 257–266.
Roque H , Paidas MJ , Funai EF et al. Maternal thrombophilias are not associated with early pregnancy loss. Thrombosis and Haemostasis 2004; 91: 290–295.
Rowan JA , McCowan LM , Raudkivi PJ , North RA . Enoxaparin treatment in women with mechanical heart valves during pregnancy. American Journal of Obstetrics Gynecology 2001; 185: 633–637.
Royal College of Obstetricians and Gynaecologists . Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Guideline no.37. London, RCOG Press, 2009.
Royal College of Obstetricians and Gynaecologists . Reducing the risk of Thrombosis and Embolism during pregnancy and the puerperium. Guideline no.37. London, RCOG Press, 2009.
Royal College of Obstetricians and Gynaecologists . Report of the RCOG Working Party on prophylaxis against thromboembolism in gynaecology and obstetrics. London, RCOG Press, 1995.
Royal College of Obstetricians and Gynaecologists . Thromboembolic disease in pregnancy and the puerperium : acute management. Green-top guideline 28, 2007.
Royal College of Obstetricians and Gynaecologists . Thromboembolic disease in pregnancy and the puerperium: acute management. RCOG Green Top Guideline 2007, No 28.
Royal College of Obstetricians and Gynaecologists . Thromboprophylaxis during pregnancy, labour and after normal vaginal delivery. Guideline no.37. London, RCOG Press, 2004.
Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. RCOG Green Top Guideline 2009, No 37.
Royal Institute for Clinical Excellence . Guidance on the use of routine antenatal anti-D prophylaxis. Guideline no. 22. RCOG Press, 2002.
Ruch WA , Klein RL . Polycythaemia vera and pregnancy: report of a case. Obstetrics and Gynecology 1964; 23: 107–111.
Ruggeri M , Tosetto A , Castaman G , Rodeghiero F . Pulmonary embolism after pregnancy in a patient with polycythemia vera. American Journal of Hematology 2001; 67: 216–217.
Ruma MS , Moise KJ , Kim E et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunisation. American Journal of Obstetrics and Gynecology, 2007; 196: 138.e1–138.e6.
Sadler JE . Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008; 112: 11–18.
Sadler L , McCowan L , White H . Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG: An International Journal of Obstetrics and Gynaecology 2000; 107: 245–253.
Sainio S , Kekomaki R , Riikonen S , Teramo K . Maternal thrombocytopenia at term: a population-based study. Acta Obstetrica Gynecologica Scandinavica 2000; 79:744–749.
Salomon LJ , deTayrac R , Castaigne-Meary V et al. Fertility and pregnancy outcome following pelvic arterial embolization for severe post-partum haemorrhage. A cohort study. Human Reproduction 2003; 18: 849–852.
Salomon O , Steinberg DM , Tamarin I et al. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagulation and Fibrinolysis 2005; 16: 37–41.
Salooja N , Szydlo RM , Socie G et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective study. The Lancet 2001; 358: 271–276.
Sanchez-Luceros A , Farias CE , Amaral MM et al. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thrombosis and Haemostasis 2004; 92: 1320–1326.
Sanchez-Luceros A , Meschengieser SS , Marchese C . et al. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coagulation and Fibrinolysis 2003; 14: 647–651.
Sanders JE , Buckner CD , Amos D et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. Journal of Clinical Oncology. 1988; 6: 813–818.
Scarsbrook AF , Evans AL , Owen AR , Gleeson FV . Diagnosis of suspected venous thromboembolic disease in pregnancy. Clinical Radiology 2006; 61: 1–12.
Scottish Intercollegiate Guidelines Network . Section 7 Spinal and epidural blocks; Section 9 Pregnancy and puerperium. In: Prophylaxis of Venous Thromboembolism. Publication No. 62. Edinburgh, SIGN 2002; 24–26; 30–35.
Scully M , Starke R , Lee R et al. Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagulation and Fibrinolysis 2006; 17: 459–463.
Segal JB , Powe NR . Prevalence of immune thrombocytopenia: analyses of administrative data. Journal of Thrombosis and Haemostasis 2006; 4: 2377–2383.
Serjeant GR , Loy LL , Crowther M et al. Outcome of pregnancy in homozygous sickle cell disease. Obstetrics and Gynaecology 2004; 103: 1278–1285.
Serjeant GR . Sickle Cell Disease. Oxford: Oxford University Press, 1992.
Shamseddine A , Chehal A , Usta I et al. Thrombotic thrombocytopenic purpura and pregnancy: report of four cases and literature review. Journal of Clinical Apheresis, 2004; 19: 5–10.
Sharma SK , Philip J , Wiley J . Thromboelastographic changes in healthy parturients and postpartum women. Anesthesia and Analgesia 1997; 85: 94–98.
Shetty S , Ghosh K , Pathare A , Mohanty D . Carrier detection in haemophilia A families: comparison of conventional coagulation parameters with DNA polymorphism analysis – first report from India. Haemophilia 2001; 5: 243–246.
Sifakis S , Angelakis E , Vardaki E et al. Erythropoietin in the treatment of iron deficiency anemia during pregnancy. Gynecological Obstetric Investment 2001; 51: 150–156.
Sikkel E , Vandenbussche FPHA , Oepkes D et al. Amniotic fluid ΔOD450 values accurately predict severe fetal anaemia in D-alloimmunisation. Obstetrics and Gynecology 2002; 100: 51–57.
Silver RM , Landon MB , Rouse DT et al. Maternal morbidity associated with multiple repeat cesarean delivery. Obstetrics and Gynaecology 2006; 107: 1226–1236.
Smith JA , Espeland M , Bellevue R et al. Pregnancy in sickle cell disease: experience of the cooperative study of sickle cell disease. Obstetrics and Gynaecology 1996; 87: 199–204.
Sokol RJ , Hewitt S , Stamps BK . Erythrocyte autoantibodies, autoimmune haemolysis and pregnancy. Vox Sanguinis 1982; 43: 169–176.
Sood R , Kalloway S , Mast AE , Hilard CJ , Weiler H . Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood 2006; 107(8): 3173–3181.
Spencer JA , Burrows RF . Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Australia and New Zealand Journal of Obstetrics and Gynaecology 2001; 41: 45–55.
Stafford Smith M. Impaired haemostasis and regional anaesthesia. Canadian Journal of Anesthesia 1996; 43: R129–R141.
Stainsby D , MacLennan S , Thomas D et al. Guidelines on the management of massive blood loss. British Journal of Haematology 2006; 135: 634–641.
Stanworth S , Birchall J , Doree C , Hyde C . Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database of Systematic Reviews 2007; 18: CD005011.
Steffens M , Beauloye V , Brichard B et al. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma (NHL). Clinical Endocrinology 2008; 69: 819–827.
Stirling Y , Woolf L , North WR , Seghatchian et al. Haemostasis in normal pregnancy. Thrombosis and Haemostasis 1984; 52: 176–182.
Stirling Y , Woolf L , North WRS et al. Haemostasis in normal pregnancy. Thrombosis and Haemostasis 1984; 52: 176–182.
Subtil D , Deruelle P , Trillot N , Jude B . Preclinical phase of polycythemia vera in pregnancy. Obstetrics and Gynecology 2001; 98: 945–947.
Sullivan I , Faulds J , Ralph C . Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section. British Journal of Anaesthesia 2008; 101: 225–229.
Taylor DJ , Lind T . Red cell mass during and after normal pregnancy. British Journal of Obstetrics and Gynaecology 1979; 86: 364–370.
Taylor UB , Bardeguez AD , Iglesias N , Gascon P . Idiopathic myelofibrosis in pregnancy: a case report and review of the literature. American Journal of Obstetrics and Gynecology 2004; 167: 38–39.
The role of emergency and elective interventional radiology in postpartum haemorrhage – good practice No. 6 Royal College of Obstetricians and Gynaecologists, June 2007.
The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology . Guidelines on the diagnosis and management of acute pulmonary embolism. European Heart Journal 2008; 29: 2276–2315.
Thompson CE , Damon LE , Ries CA , Linker CA . Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 1992; 80: 1890–1895.
Thomson AJ , Walker ID , Greer IA . Low molecular weight heparin for the immediate management of thromboembolic disease in pregnancy. The Lancet 1998; 352: 1904.
Triolo G , Ferrante A , Ciccia F et al. Randomised study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss. Arthritis and Rheumatism 2003; 48: 728–731.
Tsuei BJ , Kearney PA . Hypothermia in the trauma patient. Injury 2004; 35: 7–15.
Tulpule S , Bewley S , Robinson SE , Radia D , Nelson-Piercy C , Harrison CN . The management and outcome of 4 pregnancies in women with idiopathic myelopfibrosis. British Journal of Haematology 2008; 142: 480–482.
Tupule S , Bewley S , Robinson SE et al. The management and outcome of 4 pregnancies in women with idiopathic myelofibrosis. British Journal of Haematology 2008; 142: 480–482.
Turner ML , Bessos H , Fagge T et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005; 45: 1945–1956.
Turpie AGG, Gent M , Laupacis A et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. New England Journal of Medicine 1994; 329: 524–529.
UK National Institute for Health and Clinical Excellence. Intraoperative blood cell salvage in obstetrics. IP Guidance Number: IPG144. Available from URL: http://www.nice.org.uk/guidance
United Kingdom Thalassemia Society Standards for the Clinical Care of Children and Adults with Thalassemia in the UK, 2005.
Urbaniak SJ . Noninvasive approaches to the management of RhD haemolytic disease of the fetus and newborn. Transfusion 2008; 48: 2–5.
Valdimarsson H , Mulholland C , Fridriksdottir V et al. A longitudinal study of leucocyte blood counts and lymphocyte responses in pregnancy: a marked early increase of monocyte-lymphocyte ratio. Clinical and Experimental Immunology 1983; 53: 437–443.
Van Driel D , Wesseling J , Sauer PJJ et al. Teratogen update: feta; effects ofter in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology 2002; 66: 127–140.
Veneri D , Franchini M , Raffaelli R et al. Idiopathic thrombocytopenic purpura in pregnancy: analysis of 43 consecutive cases followed at a single Italian institution. Annals of Hematology 2006; 85: 552–554.
Venkatesha S , Toporsian M , Lam C et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Medicine 2006; 12: 642–649.
Verdy E , Bessous V , Dreyfus M et al. Longitudinal analysis of platelet count and volume in normal pregnancy. Thrombosis and Haemostasis 1997; 77: 806–807.
Vesely SK , George JN , Lammle B et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003; 102: 60–68.
Vesely SK , Li X , McMinn JR , Terrell DR , George JN . Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura–hemolytic uremic syndrome. Transfusion 2004; 44: 1149–1158.
Vincelot A , Nathan N , Collert D et al. Platelet function during pregnancy: an evaluation using the PFA-100 analyser. British Journal of Anaesthesia 2001; 87: 890–893.
Vitale N , De Feo M , Cotrufo M . Anticoagulation for prosthetic heart valves during pregnancy: the importance of warfarin daily dose. European Journal of Thoracic and Cardiovascular Surgery 2002; 22: 656.
Vossen CY , Preston FE , Conard J et al. Hereditary thrombophilia and fetal loss: a prospective follow-up study. Journal of Thrombosis and Haemostasis 2004; 2: 592–596.
Walker ID , Greaves M , Preston FE . Investigation and management of heritable thrombophilia. British Journal of Haematology 2001; 114: 512–528.
Walker MC , Smith GN , Perkins SL et al. Changes in homocysteine levels during normal pregnancy. American Journal of Obstetrics and Gynecology 1999;180: 660–4.
Wallace WH , Shalet SM , Crowne EC et al. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clinical Oncology. 1989; 1: 75–79.
Wallace WHB , Thomson AB , Kelsey TW . The radiosensitivity of the human oocyte. Human Reproduction. 2003; 18: 117–121.
Warshak CR , Eskander R , Hull AD et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstetrics and Gynaecology 2006; 108: 573–582.
Waters JH , Biscotti C , Potter PS , Phillipson E . Amniotic fluid removal during cell salvage in caesarean section patients. Anesthesiology 2000; 92: 1531–1536
Webert KE , Mittal R , Sigouin C et al. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 2003; 102: 4306–4311.
Weeks SM , Stroud TH , Sandhu J et al. Temporary balloon occlusion of the internal iliac arteries for control of hemorrhage during caesarean hysterectomy in a patient with placenta previa and placenta increta. Journal of Vascular and Interventional Radiology 2000; 11: 622–624.
Wilson W , Taubert KA , Gewitz M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116: 1736–1754.
Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis and Rheumatism 1999; 42: 1309–1311.
Win N , Rowley M , Pollard C et al. Severe gestational (incidental) thrombocytopenia: to treat or not to treat. Haematology 2005; 10: 69–72.
World Health Report . Make every mother and child count. http://who.int/whr/2005_en.pdf 2005; accessed 19th May 2008.
Wright CA , Tefferi A . A single institutional experience with 43 pregnancies in essential thrombocythemia. European Journal of Haematology 2001; 66: 152–159.
Wu S , Kocherginsky M , Hibbard JU . Abnormal placentation: twenty-year analysis. American Journal of Obstetrics and Gynaecology 2005; 192: 1458–1461.
Wysowski DK , Talarico L , Bacsanyi J , Botstein P . Spinal and epidural haematoma and low molecular weight heparin. New England Journal of Medicine 1998; 338: 1774–1775.
Yamada H , Kato E , Kobashi G et al. Passive immune thrombocytopenia in neonates of mothers with idiopathic thrombocytopenic purpura: incidence and risk factors. Seminars in Thrombosis Hemostasis. 1999; 25: 491–496.
Yang D , Brown SE , Nguyen K et al. Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment. Fertility and Sterility 2007; 87: 1469.e1–4.
Yetman DL , Kutteh WH . Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertility and Sterility 1996; 66: 540–546.
Zaki ZM , Bahar AM , Ali ME et al. Risk factors and morbidity in patients with placenta previa accreta compared to placenta previa non-accreta. Acta Obstetrics and Gynaecologica Scandinavica 1998; 77: 391–394.
Zhao S , Xiaofeng S . Clinical study in curing postpartum haemorrhage in the third stage of labor. Journal of Practical Obstetrics and Gynecology 2003; 19: 278–280.